Medical Apps for Cardiology Uses. There s an App for That!

Similar documents
Quality Payment Program: Cardiology Specialty Measure Set

Peripheral Arterial Disease Medical Approach and Management

Atrial Fibrillation and the NOAC s. John Raymond MS, PA-C, MHP February 10, 2018

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Quality Measures MIPS CV Specific

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set

2017 Bryan Health Primary Care Conference. Dale Hansen MD Bryan Heart 5/20/17

Quality Payment Program: Cardiology Specialty Measure Set

New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0.

Update in the Literature 2012

Patient Encounters in the Primary Care Setting

Atrial Fibrillation. Ivan Anderson, MD RIHVH Cardiology

SONOGRAPHER & NURSE LED VALVE CLINICS

Cost and Prevalence of A fib. Atrial Fibrillation: Guideline Directed Treatment. Prevalence of A Fib. Risk Factors for A Fib. Risk Factors for A Fib

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Lipid Management 2013 Statin Benefit Groups

RF & RHD Workshop 22 nd March MANAGEMENT of RHEUMATIC HEART DISEASE in PREGNANCY. Dr Dorothy Radford

Conflict of interest statement

Update in Cardiology What s Hot in 2017?

Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근

ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION

Controversies in Atrial Fibrillation and HF

Primary Prevention of Stroke

Practice-Level Executive Summary Report

VanderbiltEM.com. Atrial Fibrillation Update Don t Miss a Beat ACEP Atrial Fibrillation is Common

2016 Internal Medicine Preferred Specialty Measure Set

Coronary Artery Disease (CAD) Clinician Guide SEPTEMBER 2017

Supplementary Online Content

Consensus Core Set: Cardiovascular Measures Version 1.0

Atrial Fibrillation. 2 nd Annual National Hospitalist Conference San Antonio, TX September 7, 2018

Atrial Fibrillation Topics for Today. Clinical Controversies Management of Atrial Fibrillation. Atrial Fibrillation in the ER Topics for Today

MMS/Mass Coalition Program, Nov. 4, 2008 Patients with AF: Who Should be on Warfarin?

An EMR Specifically Designed for the Cardiovascular Practice

Cardiac Perioperative Risk Assessment American Heart Association Guidelines

NOACs in AF. Dr Fiona Stewart. Auckland Heart Group and Auckland DHB

1000 Lives Key Components of Reliable, Evidence-Based Chronic Heart Failure Care how do we compare?

Incorporating KT Concepts within Clinical Trials

Dysrhythmias 11/7/2017. Disclosures. 3 reasons to evaluate and treat dysrhythmias. None. Eliminate symptoms and improve hemodynamics

Atrial Fibrillation Implementation challenges. Lesley Edgar Ross Maconachie

Atrial Fibrillation and Heart failure

4/27/2015. Cardiac Events #1 cause of postoperative complications/ mortality- CHF, complete heart block, MI,

HEART FAILURE: PHARMACOTHERAPY UPDATE

Occlusion de l'auricule gauche: Niche ou réel avenir? D Gras, MD, Nantes, France

Dr Chris Ellis. Consultant Cardiologist Auckland City Hospital Auckland

Pre-op Risk Assessment. Hal Blanks MD FACC

AF Diagnosis. Incorporated into over 75 health checks and Public Health Checks

SUPPLEMENTAL MATERIAL

New Hypertension Guidelines. Kofi Osei, MD

Clinical Controversies in Perioperative Medicine

Manuel Castellá Cardiovascular Surgery Hospital Clínic, Universidad de

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies

6 th ACC-SHA Joint Meeting Jeddah, Saudi Arabia

8:30-10:30 WS #4: Cardiology :00-13:00 WS #11: Cardiology 101 (Repeated)

Common Codes for ICD-10

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)

Atrial Fibrillation. A guide for Southwark General Practice. Key Messages. Always work within your knowledge and competency

INR as a Biomarker: Anticoagulation in Atrial Fib, Heart Failure, and Cardiovascular Disease Daniel Blanchard, MD, FACC, FAHA

The Atrial Fibrillation Clinic in Llanelli. Dr Lena Marie Izzat Consultant Cardiovascular Physician

t. Recommendations for periprocedural anticoagulation are available lhrough the American College of Chest Physicians Clinical Practice Guidelines.

Condition Congestive heart failure I11.0; I13.0; I13.2; I42.0; I50 CO3C Left ventricular dysfunction I50.1; I50.9 E11 1; E11 9

To Bridge or Not to Bridge? Preop Evaluation of the Patient on Coumadin

Innovations in AF Management

Aha blood pressure guidelines 2016 chart. Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu

Show Me the Outcomes!

Atrial Fibrillation is Common. The (S)Low-down on Rapid Afib Resuscitation Step ED Dx - Rx 4/4/2017. There Are 5 Causes of Atrial Fibrillation

L. Fauchier (1), S. Taillandier (1), I. Lagrenade (1), C. Pellegrin (1), L. Gorin (1), A. Bernard (1), B. Rauzy (1), D. Babuty (1), GYL.

Afib, Stroke, and DOAC. Albert Luo, MD. Cardiology Lindsey Frischmann, DO. Neurology Xiao Cai, MD. HBS

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

NEWLY DETECTED ATRIAL FIBRILLATION. Edgar S. Carell, M.D. Director, Vascular Medicine Clinic West Suburban Cardiology

Thrombosis Canada Clinical Tools. Perioperative Management of Anticoagulants Antithrombotic Use in Atrial Fibrillation

Objectives. Falling Down on Warfarin Therapy. CHADS 2 Score. CHADS 2 & CHA 2 DS 2 -VASc Score. HAS-BLED Score 04/08/2014. Real World Application

심방세동과최신항응고요법 RACE II AFFIRM 항응고치료는왜중요한가? Rhythm control. Rate control. Anticoagulation 남기병 서울아산병원내과. Clinical Impact of Atrial Fibrillation

Challenging Anticoagulation Case Studies. Earl J. Hope, M.D. Tower Health Cardiology

Disclosures. Overview. Have you ever. The Perioperative Management of Anticoagulants. No financial conflicts of interest to disclose

2016 General Practice/Family Practice Preferred Specialty Measure Set

Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use

Topic: Chronic Heart Failure Cases for Monday s March 21th lecture.

Acta Orthopaedica 2016; 87 (Id.no 10437) Supplementary article data (1/5)

SUMMARY OF CHANGES TO QOF 2017/18 - ENGLAND CLINICAL

VanderbiltEM.com. Atrial Fibrillation Update Don t Miss a Beat ACEP AFib. 20 Facts on Atrial Fibrillation in 20 minutes

MITRAL VALVE DISEASE- ASSESSMENT AND MANAGEMENT. Irene Frantzis P year, SGUL Sheba Medical Center

17/18 Threshold 18/19 Points 18/19. Points NO CHANGE NO CHANGE NO CHANGE

HEART OF THE MATTER: cardiac issues in safe endoscopy & sedation

Summary of Research and Writing Activities In Cardiovascular Disease

Asif Serajian DO FACC FSCAI

Dual Antiplatelet Therapy Made Practical

SUPPLEMENTAL MATERIAL

Coronary Heart Disease. Iqbal Malik

Atrial Fibrillation and Heart Failure: A Cause or a Consequence

14/15 Threshold 15/16 Points 15/16. Points. Retired Replaced by NM82/AF007. Replacement NO CHANGE

AF stroke prevention in the Canadian context

Surgery and device intervention for the elderly with heart failure: assessing the need. Devices and Technology for heart failure in 2011

Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD)

CARDIAC REHABILITATION PROGRAMME:- MEDICATION

Conflict Disclosures. Vermont Cardiac Network. Outline. Series Learning Objectives 4/27/2016. Scott E. Friedman April 28, 2016

Alex versus Xience Registry Preliminary report

Watchman and Structural update..the next frontier. Ari Chanda, MD Cardiology Associates of Fredericksburg

DECLARATION OF CONFLICT OF INTEREST

Case Discussion. 18 th Annual UCSD Heart Failure Symposium

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Transcription:

Medical Apps for Cardiology Uses There s an App for That!

Audience Participation Question #1 1. ASCVD Risk App What is the predicted 10 year CV event rate for a 57 y/o black male patient with treated BP of 150/85 and total cholesterol 180 and HDL cholesterol of 35? (Remember statin recommended if the 10 year CV event risk above 7.5%?) A. 4% B. 8% C. 13% D. 17%

Audience Participation Question #1 1. ASCVD Risk App What is the predicted 10 year CV event rate for a 57 y/o black male patient with treated BP of 150/85 and total cholesterol 180 and HDL cholesterol of 35? (Remember statin recommended if the 10 year CV event risk above 7.5%?) A. 4% B. 8% C. 13% D. 17%

Audience Participation Question #2 ASCVD Risk App What is the 10 year CV event rate for a white female with the same parameters (age 57, treated BP 150/85, total cholesterol 180, HDL 35)? A. 4% B. 8% C. 13% D. 17%

Audience Participation Question #2 ASCVD Risk App What is the 10 year CV event rate for a white female with the same parameters (age 57, treated BP 150/85, total cholesterol 180, HDL 35)? A. 4% B. 8% C. 13% D. 17%

2. STATATP III App How different is the new ASCVD risk calculator from the previous ATP III risk assessment?

Audience Participation Question #3 3. MedCalc App What is the CHA2DS2-VASC Score and annual stroke risk for a 76 y/o female patient with atrial fibrillation,hypertension & CHF with chronic renal insufficiency before anticoagulation? CHA2DS2-VASC Score A. 2 3% B. 3 4% C. 4 5% D. 5 7% annual stroke risk

Audience Participation Question #3 3. MedCalc App What is the CHA2DS2-VASC Score and annual stroke risk for a 76 y/o female patient with atrial fibrillation, hypertension & CHF with chronic renal insufficiency before anticoagulation? CHA2DS2-VASC Score A. 2 3% B. 3 4% C. 4 5% D. 5 7% annual stroke risk

Audience Participation Question #4 4. ACC Anticoag Evaluator What is the predicted annual stroke risk vs major bleeding risk in this same 76y/o female patient with atrial fibrillation, hypertension, CHF, and chronic renal insufficiency if she is treated with warfarin? Annual stroke risk major bleeding risk A. 2% 2% B. 3% 6% C. 5% 3% D. 8% 1%

Audience Participation Question #4 4. ACC Anticoag Evaluator What is the predicted annual stroke risk vs major bleeding risk in this same 76y/o female patient with atrial fibrillation, hypertension, CHF, and chronic renal insufficiency if she is treated with warfarin? Annual stroke risk major bleeding risk A. 2% 2% B. 3% 6% C. 5% 3% D. 8% 1%

Audience Participation Question #5 4. ACC Anticoag Evaluator What is the predicted annual stroke risk vs major bleeding risk in this same 76y/o female patient with atrial fibrillation, hypertension, CHF, and chronic renal insufficiency if she is treated with aspirin alone? Annual stroke risk major bleeding risk A. 2% 2% B. 3% 6% C. 5% 3% D. 8% 1%

Audience Participation Question #5 4. ACC Anticoag Evaluator What is the predicted annual stroke risk vs major bleeding risk in this same 76y/o female patient with atrial fibrillation, hypertension, CHF, and chronic renal insufficiency if she is treated with aspirin alone? Annual stroke risk major bleeding risk A. 2% 2% B. 3% 6% C. 5% 3% D. 8% 1%

5. AUC Nuclear Should I order a stress nuclear scan on my patient with history of CHF who cannot exercise who is seen in pre-op evaluation before hip surgery? Should I order a stress nuclear scan on my patient who suffered a non-stemi 2 months ago and no chest pain since?

5. AUC Nuclear Should I order a stress nuclear scan on my patient with history of CHF who cannot exercise who is seen in pre-op evaluation before hip surgery? Should I order a stress nuclear scan on my patient who suffered a non-stemi 2 months ago and no chest pain since?

5. AUC Nuclear Should I order a stress nuclear scan on my patient who suffered a non-stemi 2 months ago and no chest pain since? What if 6 months post non-stemi and no chest pain since?

6. AUC Echo Should I order an echocardiogram on my patient with mild aortic valve stenosis on last echocardiogram 2 ½ years ago without new symptoms? Or on my patient with moderate aortic valve stenosis on last echocardiogram 1 year ago without new symptoms? Or on my patient with history of mitral valve replacement 2 years ago without new symptoms?

AUC Echo Should I order an echocardiogram on my patient with mild aortic valve stenosis on last echocardiogram 2 ½ years ago without new symptoms? Or on my patient with moderate aortic valve stenosis on last echocardiogram 1 year ago without new symptoms? Or on my patient with history of mitral valve replacement 2 years ago without new symptoms?

AUC Echo Should I order an echocardiogram on my patient without new symptoms with mild aortic valve stenosis on last echocardiogram 2 ½ years ago? Or on my patient without symptoms with moderate aortic valve stenosis on last echocardiogram 1 year ago? Or on my patient with history of mitral valve replacement 2 years ago without new symptoms?

Audience Participation Question #6 7. Seattle HF App What is the predicted 5 year survival for a 72 year old man weighting 80 kg with ischemic heart disease, systolic BP 110, with class 2-3 CHF and LVEF 0.35 without treatment? A. 33% B. 44% C. 55% D. 66%

Audience Participation Question #6 7. Seattle HF App What is the predicted 5 year survival for a 72 year old man weighting 80 kg with ischemic heart disease, systolic BP 110, with class 2-3 CHF and LVEF 0.35 without treatment? A. 33% B. 44% C. 55% D. 66%

7. Seattle HF App How much is my CHF patient s risk reduced by treatments with beta blocker, ACE inhibitor, spironolactone, and defibrillator? Example: 72 year-old man with blood pressure 110/70, LVEF 0.35, ischemic heart disease, and newly diagnosed class 2-3 CHF